The condition is characterized by severe muscle pain, weakness, and dark brown or cola-colored urine
Rituximab has also been used to treat anti-NMDA receptor encephalitis (Ikeguchi et al, 2012) supporting a close link between autoimmunity, glutamate/GABA and encephalitis
The mechanism is not an increase in acid production itself, but rather how the medication changes the timing and pressure of digestive movement
Weight-loss medications are often handled like a locked door with several keys
NAD+ therapy can support cellular energy and recovery during the off-cycle, complementing gains made during active peptide treatment
primary-cta Other Important Safety Considerations This medication is not recommended for people with a seizure disorder, a current or past diagnosis of anorexia or bulimia, or anyone going through alcohol or benzodiazepine withdrawal